ATE271560T1 - Verbindungen mit antiviraler aktivität - Google Patents

Verbindungen mit antiviraler aktivität

Info

Publication number
ATE271560T1
ATE271560T1 AT97922075T AT97922075T ATE271560T1 AT E271560 T1 ATE271560 T1 AT E271560T1 AT 97922075 T AT97922075 T AT 97922075T AT 97922075 T AT97922075 T AT 97922075T AT E271560 T1 ATE271560 T1 AT E271560T1
Authority
AT
Austria
Prior art keywords
compounds
antiviral activity
positions
hydroxyl groups
low
Prior art date
Application number
AT97922075T
Other languages
German (de)
English (en)
Inventor
Shuji Fujita
Masaaki Numata
Kazuo Suzuki
Shigeki Nunomura
Mamoru Sugimoto
Masaki Terada
Original Assignee
Nissin Food Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Food Products Ltd filed Critical Nissin Food Products Ltd
Application granted granted Critical
Publication of ATE271560T1 publication Critical patent/ATE271560T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97922075T 1996-05-16 1997-05-16 Verbindungen mit antiviraler aktivität ATE271560T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12202596 1996-05-16
PCT/JP1997/001654 WO1997043296A1 (en) 1996-05-16 1997-05-16 Novel compounds having antiviral activity

Publications (1)

Publication Number Publication Date
ATE271560T1 true ATE271560T1 (de) 2004-08-15

Family

ID=14825732

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97922075T ATE271560T1 (de) 1996-05-16 1997-05-16 Verbindungen mit antiviraler aktivität

Country Status (8)

Country Link
US (3) US6337390B1 (https=)
EP (1) EP0957107B1 (https=)
JP (1) JP4099234B2 (https=)
AT (1) ATE271560T1 (https=)
AU (1) AU737680C (https=)
CA (1) CA2255070C (https=)
DE (1) DE69729958T2 (https=)
WO (1) WO1997043296A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957107B1 (en) * 1996-05-16 2004-07-21 Nissin Food Products Co., Ltd. Novel compounds having antiviral activity
WO1999043689A1 (fr) * 1998-02-27 1999-09-02 Meiji Milk Products Co., Ltd. Nouveaux derives de kdn et medicaments les contenant sous forme de principes actifs
EP1144420B1 (en) * 1999-01-15 2003-12-10 Board Of Trustees Of The University Of Illinois Sulfated phosphatidylinositols, their preparation and use
WO2003049672A2 (en) * 2001-10-30 2003-06-19 Microbiotix, Inc. Methods and compositions for treating flavivirus-mediated disease
JP2008074720A (ja) * 2006-09-19 2008-04-03 Noguchi Inst Ｇｍ３糖鎖プローブ
CA2685127C (en) 2007-04-23 2019-01-08 Alnylam Pharmaceuticals, Inc. Glycoconjugates of rna interference agents
WO2009082606A2 (en) 2007-12-04 2009-07-02 Alnylam Pharmaceuticals, Inc. Folate conjugates
AU2014277867B2 (en) * 2007-12-04 2016-11-03 Arbutus Biopharma Corporation Targeting lipids
WO2009073809A2 (en) 2007-12-04 2009-06-11 Alnylam Pharmaceuticals, Inc. Carbohydrate conjugates as delivery agents for oligonucleotides
CA2721183C (en) 2008-04-11 2019-07-16 Alnylam Pharmaceuticals, Inc. Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
JP5327839B2 (ja) * 2008-06-09 2013-10-30 国立大学法人埼玉大学 シアル酸誘導体の製造方法とインフルエンザウィルス阻害剤としての利用
MY155507A (en) * 2009-07-07 2015-10-30 Adenovir Pharma Ab Antiviral compounds
KR102545316B1 (ko) 2014-11-10 2023-06-22 알닐람 파마슈티칼스 인코포레이티드 Ｂ형 간염 바이러스(ｈｂｖ) ｉｒｎａ 조성물 및 그의 이용 방법
US20180235989A1 (en) * 2015-08-19 2018-08-23 National Research Council Canada Treatment and prevention of neisseria gonorrhoeae infection using cmp-activated nonulosonate analog compounds
US11324820B2 (en) 2017-04-18 2022-05-10 Alnylam Pharmaceuticals, Inc. Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
JP7625512B2 (ja) 2018-08-13 2025-02-03 アルナイラム ファーマシューティカルズ， インコーポレイテッド Ｂ型肝炎ウイルス（ＨＢＶ）ｄｓＲＮＡ物質組成物およびその使用方法
AU2022365434A1 (en) * 2021-10-14 2024-05-02 Owlstone Medical Limited Method for the synthesis of evoc probes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164798A (ja) 1983-03-09 1984-09-17 Rikagaku Kenkyusho シアル酸含有糖脂質誘導体
JPH064671B2 (ja) 1985-04-02 1994-01-19 メクト株式会社 シアル酸誘導体及びその製造方法
JPS62212335A (ja) 1986-03-14 1987-09-18 Mitsui Toatsu Chem Inc ２−アリ−ル−２−メチルプロピルエ−テル誘導体およびそれを有効成分として含有する殺虫剤
JPS6345223A (ja) 1986-04-04 1988-02-26 Ueno Seiyaku Oyo Kenkyusho:Kk ひと免疫不全ウイルス性疾患処置剤
JPS63264493A (ja) 1986-12-29 1988-11-01 Mect Corp 活性カルボニル基を持つシアル酸誘導体
JPS6452794A (en) 1987-05-29 1989-02-28 Kanto Ishi Pharma Co Ltd Sialic acid-containing thioglycerolipid derivative and production thereof
JPH01125394A (ja) 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
JPH02304025A (ja) 1989-05-18 1990-12-17 Tanabe Seiyaku Co Ltd 抗レトロウィルス薬
JPH0317020A (ja) * 1989-06-14 1991-01-25 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
JPH03246297A (ja) * 1990-02-22 1991-11-01 Nippon Koutai Kenkyusho:Kk ガングリオシド誘導体及びこれを含有する抗ｈｉｖ剤
JPH04136001A (ja) 1990-09-27 1992-05-11 Tanabe Seiyaku Co Ltd β―シクロデキストリン・スルホンアミド誘導体のポリ硫酸エステル及びその製法
CA2105345A1 (en) * 1992-09-02 1994-03-03 Petrus B. Kruger Chemical compound
US5344417A (en) 1992-09-11 1994-09-06 Becton, Dickinson And Company Universal fitting for inoculation receptacles
JPH06256373A (ja) 1993-01-11 1994-09-13 Dainippon Ink & Chem Inc 硫酸化オリゴ糖配糖体アシル化物およびこれを有効成分とする抗ウイルス剤
JP3062906B2 (ja) * 1993-01-29 2000-07-12 丸金醤油株式会社 Ｎ−アセチルノイラミン酸ホモポリマーの硫酸エステル
US5663151A (en) 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
JPH09183789A (ja) 1995-10-31 1997-07-15 Sanwa Kagaku Kenkyusho Co Ltd 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途
EP0957107B1 (en) * 1996-05-16 2004-07-21 Nissin Food Products Co., Ltd. Novel compounds having antiviral activity

Also Published As

Publication number Publication date
DE69729958D1 (de) 2004-08-26
US6835720B2 (en) 2004-12-28
DE69729958T2 (de) 2005-07-28
AU2789597A (en) 1997-12-05
US20030073664A1 (en) 2003-04-17
US6541461B2 (en) 2003-04-01
CA2255070C (en) 2006-08-15
US20020077472A1 (en) 2002-06-20
EP0957107B1 (en) 2004-07-21
EP0957107A4 (https=) 1999-11-17
WO1997043296A1 (en) 1997-11-20
CA2255070A1 (en) 1997-11-20
US6337390B1 (en) 2002-01-08
AU737680C (en) 2002-05-02
JP4099234B2 (ja) 2008-06-11
AU737680B2 (en) 2001-08-30
EP0957107A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
ATE271560T1 (de) Verbindungen mit antiviraler aktivität
FI20001231L (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
ES2122472T3 (es) Derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
DK118286D0 (da) Terapeutisk aktive nucleosider, deres anvendelse og farmaceutiske kompositioner indeholdende forbindelserne
ES2046300T3 (es) Composicion para el tratamiento de la piel.
DE69832375D1 (de) Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach-medikamentresistenz in krebs- und anderen zellen
RU92016277A (ru) Микробиоциды
DE69024104D1 (de) Polypeptide und Polypeptidanaloge mit inhibitorischer Aktivität gegenüber menschlicher Elastase
DK403187A (da) Praeparat til transdermal indgift
DK0930077T3 (da) Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat
MX9206915A (es) Composicion para el cuidado de la piel.
ES2065980T3 (es) Uso del acido 5-aminosalicilico en el tratamiento de alteraciones dermatologicas.
ATE90685T1 (de) Disaccharidderivate.
ATE79034T1 (de) Behandlung von viruskrankheiten.
SE8704849D0 (sv) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
ES2169124T3 (es) Acido 4-aminomicofenolico 6-sustituido y derivados con actividad inmunosupresora.
JPS6425724A (en) Suppressant against retrovirus
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
EP0375610A3 (en) Perfluoroalkylthioglycosides
DE3885504D1 (de) Teicoplaninderivate.
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
IT1209519B (it) Composti ad attivita'cardiotrofica.
IT1197892B (it) Composizioni farmaceutiche ad attivita' cicatrizzante
ITMI921563A1 (it) Composizione schiumogena per ridurre la pressione associata all'onda d'urto generata da esplosioni
RU2000112019A (ru) Применение сульфатированных олигосахаридов для снижения уровня триглицеридов в крови

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties